Molecular Diagnostics Market Size & Share Report, 2025 – 2034

Molecular Diagnostics Market – By Product Type, By Technology, By Application, By End Use – Global Forecast, 2025 – 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definition

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Data mining sources

1.3.1&nbsp;&nbsp;&nbsp; Global

1.3.2&nbsp;&nbsp;&nbsp; Regional/Country

1.4&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.4.1&nbsp;&nbsp;&nbsp; Base year calculation

1.4.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.6&nbsp;&nbsp;&nbsp; Forecast model

1.7&nbsp;&nbsp;&nbsp; Research assumptions and limitations

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 360&deg; synopsis

2.2&nbsp;&nbsp;&nbsp; Key market trends

2.2.1&nbsp;&nbsp;&nbsp; Product type

2.2.2&nbsp;&nbsp;&nbsp; Technology

2.2.3&nbsp;&nbsp;&nbsp; Application

2.2.4&nbsp;&nbsp;&nbsp; End use

2.2.5&nbsp;&nbsp;&nbsp; Regional

2.3&nbsp;&nbsp;&nbsp; CXO perspectives: Strategic imperatives

2.3.1&nbsp;&nbsp;&nbsp; Key decision points for industry executives

2.3.2&nbsp;&nbsp;&nbsp; Critical success factors for market players

2.4&nbsp;&nbsp;&nbsp; Future outlook and strategic recommendations

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.1.1&nbsp;&nbsp;&nbsp; Supplier landscape

3.1.2&nbsp;&nbsp;&nbsp; Value addition at each stage

3.1.3&nbsp;&nbsp;&nbsp; Factor affecting the value chain

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Technological advances and increasing awareness towards early disease diagnosis globally

3.2.1.2&nbsp;&nbsp;&nbsp; Escalating demand for POC diagnostics

3.2.1.3&nbsp;&nbsp;&nbsp; Increasing geriatric population base

3.2.1.4&nbsp;&nbsp;&nbsp; Increasing number of R&amp;D initiatives

3.2.1.5&nbsp;&nbsp;&nbsp; Rising incidences of infectious diseases

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High cost of molecular diagnostic tests

3.2.2.2&nbsp;&nbsp;&nbsp; Lack of skilled personnel

3.2.3&nbsp;&nbsp;&nbsp; Market opportunities

3.2.3.1&nbsp;&nbsp;&nbsp; Expansion in emerging markets

3.2.3.2&nbsp;&nbsp;&nbsp; Integration with artificial intelligence (AI)

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Technology and innovation landscape

3.4.1&nbsp;&nbsp;&nbsp; Current technological trends

3.4.2&nbsp;&nbsp;&nbsp; Emerging technologies

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5.1&nbsp;&nbsp;&nbsp; North America

3.5.2&nbsp;&nbsp;&nbsp; Europe

3.5.3&nbsp;&nbsp;&nbsp; Asia Pacific

3.5.4&nbsp;&nbsp;&nbsp; Latin America

3.5.5&nbsp;&nbsp;&nbsp; Middle East and Africa

3.6&nbsp;&nbsp;&nbsp; Future market trends

3.7&nbsp;&nbsp;&nbsp; Pricing analysis

3.8&nbsp;&nbsp;&nbsp; Gap analysis

3.9&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.10&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.2.1&nbsp;&nbsp;&nbsp; By region

4.2.1.1&nbsp;&nbsp;&nbsp; North America

4.2.1.2&nbsp;&nbsp;&nbsp; Europe

4.2.1.3&nbsp;&nbsp;&nbsp; Asia Pacific

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Key developments

4.6.1&nbsp;&nbsp;&nbsp; Mergers and acquisitions

4.6.2&nbsp;&nbsp;&nbsp; Partnerships and collaborations

4.6.3&nbsp;&nbsp;&nbsp; New product launches

4.6.4&nbsp;&nbsp;&nbsp; Expansion plans

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product Type, 2021 &ndash; 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Instruments

5.3&nbsp;&nbsp;&nbsp; Reagents and kits

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Technology, 2021 &ndash; 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Polymerase chain reaction (PCR)

6.3&nbsp;&nbsp;&nbsp; Hybridization

6.4&nbsp;&nbsp;&nbsp; Sequencing

6.5&nbsp;&nbsp;&nbsp; Isothermal nucleic acid amplification technology (INAAT)

6.6&nbsp;&nbsp;&nbsp; Microarrays

6.7&nbsp;&nbsp;&nbsp; Other technologies

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 &ndash; 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Infectious disease diagnostics

7.2.1&nbsp;&nbsp;&nbsp; COVID-19

7.2.2&nbsp;&nbsp;&nbsp; Flu

7.2.3&nbsp;&nbsp;&nbsp; Respiratory syncytial virus (RSV)

7.2.4&nbsp;&nbsp;&nbsp; Tuberculosis

7.2.5&nbsp;&nbsp;&nbsp; CT/NG

7.2.6&nbsp;&nbsp;&nbsp; HIV

7.2.7&nbsp;&nbsp;&nbsp; Hepatitis C

7.2.8&nbsp;&nbsp;&nbsp; Hepatitis B

7.2.9&nbsp;&nbsp;&nbsp; Other infectious disease diagnostics

7.3&nbsp;&nbsp;&nbsp; Genetic disease testing

7.4&nbsp;&nbsp;&nbsp; Oncology testing

7.5&nbsp;&nbsp;&nbsp; Other applications

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2021 &ndash; 2034 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Hospitals and clinics

8.3&nbsp;&nbsp;&nbsp; Diagnostic laboratories

8.4&nbsp;&nbsp;&nbsp; Other end use

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2034 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Spain

9.3.5&nbsp;&nbsp;&nbsp; Italy

9.3.6&nbsp;&nbsp;&nbsp; Netherlands

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; China

9.4.2&nbsp;&nbsp;&nbsp; Japan

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; South Korea

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Argentina

9.6&nbsp;&nbsp;&nbsp; Middle East and Africa

9.6.1&nbsp;&nbsp;&nbsp; South Africa

9.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.3&nbsp;&nbsp;&nbsp; UAE

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

10.2&nbsp;&nbsp;&nbsp; Agilent Technologies

10.3&nbsp;&nbsp;&nbsp; Becton, Dickinson, and Company

10.4&nbsp;&nbsp;&nbsp; Biocartis

10.5&nbsp;&nbsp;&nbsp; Biomerieux

10.6&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories

10.7&nbsp;&nbsp;&nbsp; Danaher Corporation

10.8&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche

10.9&nbsp;&nbsp;&nbsp; Hologic

10.10&nbsp;&nbsp;&nbsp; Huwel Lifesciences

10.11&nbsp;&nbsp;&nbsp; Illumina

10.12&nbsp;&nbsp;&nbsp; Qiagen

10.13&nbsp;&nbsp;&nbsp; QuidelOrtho Corporation

10.14&nbsp;&nbsp;&nbsp; Siemens Healthineers

10.15&nbsp;&nbsp;&nbsp; Sysmex Corporation

10.16&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific

&nbsp;&nbsp;&nbsp;

Molecular Diagnostics Market

Customize This Report